THRD - Wall Street Estimates - Third Harmonic Bio, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 5.79

1.94 %

$ 261 M

Market Cap

-5.97

P/E

Price Target Average

251.18%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

--45.50%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Third Harmonic Bio, Inc.

Wall Street analysts predict an average 1-year price target for THRD of $20.3 , with forecasts ranging from a low of $18 to a high of $23 .

THRD Lowest Price Target Wall Street Target

18 USD 210.88%

THRD Average Price Target Wall Street Target

20.3 USD 251.18%

THRD Highest Price Target Wall Street Target

23 USD 297.24%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free